electroCore, Inc. Stock News

ROCKAWAY, N.J., Aug. 12, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that Kelly Benning has been hired as the Senior Vice President of Truvaga, effective July 21, 2025.

electroCore, Inc. (NASDAQ:ECOR ) Q2 2025 Earnings Conference Call August 6, 2025 4:30 PM ET Company Participants Daniel S. Goldberger - CEO & Director Joshua S.

electroCore (ECOR 1.02%), a medical device company focused on non-invasive bioelectronic therapies, released its second quarter 2025 financial results on August 6, 2025. The release showed GAAP quarterly revenue of $7.381 million, narrowly surpassing analyst expectations of $7.24925 million (GAAP), and a record for the company.

Net sales of $7.4 million increased 20% vs. Q2'2024; YTD net sales of $14.1 million increased 22% vs. first half of 2024

ROCKAWAY, N.J., Aug. 05, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that James C.

ROCKAWAY, N.J., July 23, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report financial results for the second quarter ended June 30, 2025, after the close of the market on Wednesday, August 6, 2025.

ROCKAWAY, N.J., July 22, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate in the following investor conferences.

electroCore, Inc. (NASDAQ:ECOR ) Q1 2025 Earnings Conference Call May 7, 2025 4:30 PM ET Company Participants Dan Goldberger - Chief Executive Officer and Director Joshua Lev - Chief Financial Officer Conference Call Participants Tyler Bussian - Brookline Capital Operator Greetings, and welcome to the electroCore First Quarter 2025 Earnings Conference Call. At this time, all participants have b...